US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary: market research reports

RSS Feeds

Respiratory/Pulmonary market research reports and industry analysis

1    3    5  6  7  8  9  10  
Lung Disease - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... therapeutic development for Lung Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Respiratory Tract Inflammatory Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Analytical Tool - Lung Cancer
3/25/2014 | published by: BioSeeker Group AB
... Pipeline Update 2014". According to market analytical studies, the therapeutic lung cancer drug market is predicted to exceed $4 billion between 2010 and 2015. Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs ...  |  read more...
USD 11,625
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
3/25/2014 | published by: MarketsandMarkets
... interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was ...  |  read more...
USD 4,650
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Pulmonary Hypertension - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chronic Bronchitis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Chronic Bronchitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Small-Cell Lung Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Small-Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth
2/7/2014 | published by: GBI Research
... “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth”. The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value ...  |  read more...
USD 3,500
Respiratory Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
2014 Strategies for the Japanese Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 2,400
2014 Strategies for the US Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and ...  |  read more...
USD 3,600
2014 Strategies for the Spanish Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Strategies for the German Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Strategies for the UK Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, ...  |  read more...
USD 1,950
2014 Strategies for the Rhinovirus Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public ...  |  read more...
USD 4,350
2014 Strategies for the Respiratory Syncytial Virus Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: -Hospitals - Commercial/Private Labs ...  |  read more...
USD 4,350
2014 Strategies for the European Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific views on epidemiology ...  |  read more...
USD 8,300
2014 Strategies for the Global Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, ...  |  read more...
USD 9,850
2014 Strategies for the French Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Strategies for the Italian Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
Respiratory Diseases in France 2014: Market Outlook and Emerging Opportunities
1/23/2014 | published by: Venture Planning Group
... Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market ...  |  read more...
USD 1,950
1    3    5  6  7  8  9  10